Crossmark

Kaempferol potentiates the sensitivity of pancreatic cancer cells to erlotinib via inhibition of the PI3K/AKT signaling pathway and epidermal growth factor receptor

Crossref DOI link: https://doi.org/10.1007/s10787-021-00848-1

Published Online: 2021-07-28

Published Print: 2021-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Zhengguang https://orcid.org/0000-0003-1053-5570
Guo, Yuanyuan

Chen, Meijuan

Chen, Feiyan

Liu, Bing

Shen, Cunsi
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82004118, 82004081)

National Natural Science Foundation of China (81904029)

Natural Science Youth Foundation of Nanjing University of Chinese Medicine (NZY82004118, NZY82004081, NZY81904029)

Scientific Research Project of Jiangsu Provincial Health Commission (Z2020015)

Colleges and Universities in Jiangsu Province Natural Science Research (19KJB360010)
License Information

Text and Data Mining valid from 2021-07-28

Version of Record valid from 2021-07-28
More Information

Article History

Received: 2 May 2021

Accepted: 4 July 2021

First Online: 28 July 2021

Declarations

:

: This study was performed with approval from the Animal Ethics Committee of Nanjing University of Chinese Medicine. All experimental procedures were performed according to the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals.

Document is current

Any future updates will be listed below